Literature DB >> 21052936

Potential therapeutic agents against Alzheimer's disease from natural sources.

So-Young Park1.   

Abstract

The average human life span in developed countries has increased to more than 80 years following rapid breakthrough and developments in modern medicine and science, resulting in prolonged life expectancy and increase in the population counts of the geriatric age group. This translates into a dramatic increase in disease burden of elderly patients suffering from senile disorders including neurodegenerative diseases, particularly Alzheimer's disease (AD). AD is characterized by the death of nerve cells in the cerebral cortex and is the most common subtype of dementia that affected 25 million people worldwide in 2000 and is expected to increase to 114 million by 2050. Despite the exponential growth in the number of AD patients, only acetylcholinesterase (AChE) inhibitors are being currently used to treat AD. It is well known that AChE inhibitors can alleviate the symptoms of AD but not halt the disease progression. Consequently, therapeutic agents against AD acting at various pathologic levels are needed. In the recent decade, natural products with anti-AD properties have attracted much attention. But very few natural products have been investigated in a scientifically justifiable method for these biological activities. Following a detailed research process, it is certain that natural products have a strong potential to develop biologically active compounds with new chemical structures. Many studies have been carried out to identify the naturally occurring anti-AD agents. This review article describes the molecular targets aiming at developing the anti-AD agents including the inhibition of AChE, inhibition of Aβ production by enhancing α-secretase (non-amyloidogenic pathway) or inhibiting β- and γ-secretases (amyloidogenic pathway), alleviating Aβ-induced neurotoxicity or reducing Aβ-induced neuroinflammation. In addition, this paper summarizes the potential of some of the natural products that might inhibit specific molecular targets and slow the progression of this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052936     DOI: 10.1007/s12272-010-1010-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  14 in total

1.  Effects of Long-Term Rice Bran Extract Supplementation on Survival, Cognition and Brain Mitochondrial Function in Aged NMRI Mice.

Authors:  Stephanie Hagl; Heike Asseburg; Martina Heinrich; Nadine Sus; Eva-Maria Blumrich; Ralf Dringen; Jan Frank; Gunter P Eckert
Journal:  Neuromolecular Med       Date:  2016-06-27       Impact factor: 3.843

2.  Protective effects of phillyrin on H2O 2-induced oxidative stress and apoptosis in PC12 cells.

Authors:  Teng Wei; Wulin Tian; Haiyang Yan; Guoxi Shao; Guanghong Xie
Journal:  Cell Mol Neurobiol       Date:  2014-08-22       Impact factor: 5.046

3.  Inhibition of Toxic IAPP Amyloid by Extracts of Common Fruits.

Authors:  Pei-Yu Kao; Evangeline Green; Catalina Pereira; Shauna Ekimura; Dennis Juarez; Travis Whyte; Taylor Arhar; Bianca Malaspina; Luiza A Nogaj; David A Moffet
Journal:  J Funct Foods       Date:  2015-01-01       Impact factor: 4.451

4.  Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease.

Authors:  Adrian Orjuela; Johant Lakey-Beitia; Randy Mojica-Flores; Muralidhar L Hegde; Isaias Lans; Jorge Alí-Torres; K S Rao
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

5.  Protective Effects of Baicalin on Aβ₁₋₄₂-Induced Learning and Memory Deficit, Oxidative Stress, and Apoptosis in Rat.

Authors:  Haitao Ding; Haitao Wang; Yexia Zhao; Deke Sun; Xu Zhai
Journal:  Cell Mol Neurobiol       Date:  2015-01-18       Impact factor: 5.046

Review 6.  Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.

Authors:  Johant Lakey-Beitia; Ruben Berrocal; K S Rao; Armando A Durant
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

7.  Flavone derivatives as inhibitors of insulin amyloid-like fibril formation.

Authors:  Ricardas Malisauskas; Akvile Botyriute; Jonathan G Cannon; Vytautas Smirnovas
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Attenuation of β-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2.

Authors:  Chan Lee; Gyu Hwan Park; Seong-Ryong Lee; Jung-Hee Jang
Journal:  Oxid Med Cell Longev       Date:  2013-06-20       Impact factor: 6.543

Review 9.  Cholinesterase inhibitors from botanicals.

Authors:  Faiyaz Ahmed; Raza Murad Ghalib; P Sasikala; K K Mueen Ahmed
Journal:  Pharmacogn Rev       Date:  2013-07

10.  High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity.

Authors:  Jai-Hong Cheng; Chia-Ling Tsai; Yi-Yang Lien; Meng-Shiou Lee; Shyang-Chwen Sheu
Journal:  BMC Complement Altern Med       Date:  2016-06-07       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.